ALVO
NASDAQ · Biotechnology
Alvotech Sa
$5.95
+0.07 (+1.19%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+433.1% upside
Low Target
$22.31
Average Target
$31.72
High Target
$46.94
Current Price
$5.95
Current
$5.95
$5.95
Target
$31.72
$31.72
$22.31
$31.72 avg
$46.94
Scenario Analysis
Bear Case
$22.31
275.0%
Low target
Base Case
$31.72
+433.1%
Avg target
Bull Case
$46.94
+688.9%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$9.25
-35.7% from high
52-Week Low
$2.94
+102.4% from low
Target vs 52W High
$31.72
+242.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |